Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers

Ying,Huanchun; Qu,Donghui; Liu,Chuan; Ying,Tianshu; Lv,Jing; Jin,Shanshan; Xu,Hongying

doi:10.3892/ol.2015.2950

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers

Authors:
- Huanchun Ying
- Donghui Qu
- Chuan Liu
- Tianshu Ying
- Jing Lv
- Shanshan Jin
- Hongying Xu
View Affiliations

Affiliations: Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Gynecology and Obstetrics, Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China, Department of Oncology, The Fifth Hospital of Shenyang, Shenyang, Liaoning 110023, P.R. China, Department of Gynecology and Obstetrics, The Ninth Hospital of Shenyang, Shenyang, Liaoning 10024, P.R. China
Published online on: February 10, 2015 https://doi.org/10.3892/ol.2015.2950
Pages: 1759-1763

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the protein expression of the autophagy‑related genes, BECN1 and PTEN, and the association with drug resistance in epithelial ovarian cancers. In total, 40 patients with pathologically diagnosed epithelial ovarian cancer were divided into a chemotherapy‑sensitive group (n=20) and a chemotherapy‑resistant group (n=20), according to the results of the pre‑ or post‑operative normative chemotherapy and the post‑operative follow‑up. The protein expression of the phosphatase and tensin homolog (PTEN) and the BECN1 gene product, Beclin‑1, was analyzed using immunohistochemistry in the 40 patients with ovarian carcinoma. The positive rate of Beclin‑1 expression was significantly lower in the resistant group (35.0%) compared with the sensitive group (50.0%). The positive rate of PTEN expression was also significantly lower in the resistant group (30.0%) compared with the sensitive group (65.0%). Furthermore, the differences in the expression rates were revealed to be significant (P<0.05). The expression of Beclin‑1 was identified to be positively correlated with the expression of PTEN (rs=0.816; P<0.0001). The low expression of the Beclin‑1 and PTEN proteins in the ovarian cancer tissues was revealed to be closely associated with drug resistance. Therefore, Beclin‑1 may interact with PTEN to participate in the mechanism of drug resistance and the changes in macrophage activity observed in cases of drug‑resistant ovarian cancer.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
2	Lee S, Choi EJ, Jin C and Kim DH: Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Gynecol Oncol. 97:26–34. 2005. View Article : Google Scholar : PubMed/NCBI
3	Hara T, Nakamura K, Matsui M, et al: Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 441:885–889. 2006. View Article : Google Scholar : PubMed/NCBI
4	Huang X, Bai HM, Chen I, Li B and Lu YC: Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J Clin Neurosci. 17:1515–1519. 2010. View Article : Google Scholar : PubMed/NCBI
5	Koren I and Kimchi A: Cell biology. Promoting tumorigenesis by suppressing autophagy. Science. 338:889–890. 2012. View Article : Google Scholar : PubMed/NCBI
6	Lin HX, Qiu HJ, Zeng F, et al: Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma. PLoS One. 8:e605162013. View Article : Google Scholar : PubMed/NCBI
7	Yao Q, Chen J, Lv Y, et al: The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumour Biol. 32:1163–1171. 2011. View Article : Google Scholar : PubMed/NCBI
8	Xu LW, Qian M, Jia RP, et al: Expression and significance of microsomal prostaglandin synthase-1 (mPGES-1) and Beclin-1 in the development of prostate cancer. Asian Pac J Cancer Prev. 13:1639–1644. 2012. View Article : Google Scholar : PubMed/NCBI
9	Wan XB, Fan XJ, Chen MY, et al: Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy. 6:395–404. 2010. View Article : Google Scholar : PubMed/NCBI
10	Yue Z, Jin S, Yang C, Levine AJ and Heintz N: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
11	Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gyneeol Obstet. 105:103–111. 2009. View Article : Google Scholar
12	Kondo Y and Kondo S: Autophagy and cancer therapy. Autophagy. 2:85–90. 2006. View Article : Google Scholar : PubMed/NCBI
13	Li DM and Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57:2124–2129. 1997.PubMed/NCBI
14	Li DM and Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57:2124–2129. 1997.PubMed/NCBI
15	Lee H, Choi HJ, Kang CS, Lee HJ, Lee WS and Park CS: Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. Mod Pathol. 25:1508–1515. 2012. View Article : Google Scholar : PubMed/NCBI
16	Patel R, Gao M, Ahmad I, Fleming J, Singh LB, Rai TS, McKie AB, Seywright M, Barnetson RJ, Edwards J, et al: Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression. J Clin Invest. 123:1157–1175. 2013. View Article : Google Scholar : PubMed/NCBI
17	Molina JR, Agarwal NK, Morales FC, Hayashi Y, Aldape KD, Cote G and Georgescu MM: PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene. 31:1264–1274. 2012. View Article : Google Scholar
18	Yang L, Kuang LG, Zheng HC, et al: PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol. 9:35–39. 2003.PubMed/NCBI
19	Laudański P, Kowalczuk O, Klasa-Mazurkiewicz D, et al: Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer. Folia Histochem Cytobiol. 49:317–324. 2011. View Article : Google Scholar
20	Skírnisdóttir I and Seidal T: Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer. Int J Gynecol Cancer. 21:1024–1031. 2011. View Article : Google Scholar : PubMed/NCBI
21	Gadducci A, Guerrieri ME and Genazzani AR: New insights on the pathogenesis of ovarian carcinoma: molecular basis and clinical implications. Gynecol Endocrinol. 28:582–586. 2012. View Article : Google Scholar : PubMed/NCBI
22	Selvendiran K, Tong L, Vishwanath S, et al: EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem. 282:28609–28618. 2007. View Article : Google Scholar : PubMed/NCBI
23	Wu HJ, Wu HT, Weng DH, et al: Reversal of drug resistance in human ovarian cancer ceils by wild-type PTEN gene and its mechanisms. Zhonghua Fu Chan Ke Za Zhi. 42:612–616. 2007.(In Chinese). PubMed/NCBI
24	Yan X, Fraser M, Qiu Q and Tsang BK: Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Gynecol Oncol. 102:348–355. 2006. View Article : Google Scholar : PubMed/NCBI
25	Scarlatti F, Maffei R, Beau I, Codogno P and Ghidoni R: Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ. 15:1318–1329. 2008. View Article : Google Scholar : PubMed/NCBI
26	Sun Y, Liu JH, Jin L, et al: Over-expression of the Beclin1 gene upregulates chemosensitivity to anti-cancer drugs by enhancing therapy-induced apoptosis in cervix squamous carcinoma CaSki cells. Cancer Lett. 294:204–210. 2010. View Article : Google Scholar : PubMed/NCBI
27	Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
28	Kimmelman AC: The dynamic nature of autophagy in cancer. Genes Dev. 25:1999–2010. 2011. View Article : Google Scholar : PubMed/NCBI
29	Ahn CH, Jeong EG, Lee JW, et al: Expression of beclin-l, an autophagy-related protein, in gastric and colorectal cancers. APMIS. 115:1344–1349. 2007. View Article : Google Scholar
30	Tang H, Da L, Mao Y, et al: Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology. 49:60–71. 2009. View Article : Google Scholar
31	Edinger AL and Thompson CB: Defective autophagy leads to cancer. Cancer Cell. 4:422–424. 2003. View Article : Google Scholar